Exane Derivatives’s Incyte INCY Stock Holding History

Exane Derivatives’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,441	Closed	-$179K	–	1049
2021 Q4	$179K	Buy	2,441 +717	+42%	+$48.3K	0.04%	357
2021 Q3	$119K	Buy	1,724 +124	+8%	+$9.42K	0.03%	502
2021 Q2	$129K	Buy	1,600 +651	+69%	+$54.3K	0.03%	513
2021 Q1	$77.1K	Sell	949 -628	-40%	-$53.6K	0.02%	459
2020 Q4	$137K	Buy	1,577 +259	+20%	+$22.4K	0.04%	350
2020 Q3	$118K	Buy	1,318 +194	+17%	+$18.7K	0.03%	282
2020 Q2	$117K	Sell	1,124 -632	-36%	-$60.9K	0.03%	275
2020 Q1	$129K	Buy	1,756 +1,475	+525%	+$111K	0.04%	249
2019 Q4	$22.6K	Buy	281 +82	+41%	+$7K	﹤0.01%	386
2019 Q3	$14.8K	Hold	199	–	–	﹤0.01%	408
2019 Q2	$16.9K	Buy	+199	New	+$16K	﹤0.01%	433
2018 Q4	–	Sell	-4,432	Closed	-$308K	–	711
2018 Q3	$308K	Sell	4,432 -70,019	-94%	-$4.81M	0.06%	200
2018 Q2	$5.02M	Buy	74,451 +61,035	+455%	+$4.17M	0.84%	26
2018 Q1	$1.14M	Buy	13,416 +6,346	+90%	+$572K	0.23%	114
2017 Q4	$669K	Buy	+7,070	New	+$739K	0.12%	141

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's INCY Position: Q1 2022 in Review

Exane Derivatives sold out of Incyte (INCY) in Q1 2022, closing a stake of 2,441 shares — an estimated $179K sold.

Exane Derivatives first reported a position in INCY in Q4 2017 and held it in 15 quarters. The position peaked at $5.02M in Q2 2018. 533 funds tracked by Wall St. Rank hold INCY as of Q1 2022.

Exane Derivatives reported no remaining Incyte position as of Q1 2022 after selling out during the quarter.
Exane Derivatives sold 2,441 Incyte shares in Q1 2022, an estimated $179K.
Exane Derivatives first reported a position in Incyte in Q4 2017 and held it in 15 quarters.
Exane Derivatives's Incyte position peaked at $5.02M in Q2 2018.
533 funds tracked by Wall St. Rank held Incyte as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.